ARCHIVES

Reed To Leave NCI Next Year; Allegra Moves To Extramural Side; Ozer Heads Okla. Center.

This article is from The Cancer Letter archive.

Vol. 26 No. 29 | July 21, 2000

Download PDF Visit The Full Archive

Related Articles

Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.

April 21, 2006

Protocols Approved During The Month of September 2001

October 26, 2001

Obituary: Gregory Foltz, Swedish Medical Center Neurosurgeon

July 12, 2013

Prevention Facility For Intramural Research Approved, Also Would Involve Academic Investigators

November 1, 1991

NCI Director and Acting FDA Commissioner Andrew von Eschenbach Endorses Rep. E. Clay Shaw In Tour of Florida Congressman’s District. Von Eschenbach Praises Shaw’s “Leadership” In Seeking Funding For Research, Support of 2015 Goal.

February 3, 2006

NCI-Approved Clinical Trials

July 29, 2005